Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 338, 121-126
Abstract
No abstract availableKeywords
Funding Information
- Sanofi Genzyme
This publication has 20 references indexed in Scilit:
- Proposed Stages of Myocardial Phenotype Development in Fabry DiseaseJACC: Cardiovascular Imaging, 2019
- Fabry disease revisited: Management and treatment recommendations for adult patientsMolecular Genetics and Metabolism, 2018
- The value of ECG parameters as markers of treatment response in Fabry cardiomyopathyHeart, 2016
- Electrocardiographic Changes and Arrhythmia in Fabry DiseaseFrontiers in Cardiovascular Medicine, 2016
- R-Peak Time: An Electrocardiographic Parameter with Multiple Clinical ApplicationsAnnals of Noninvasive Electrocardiology, 2015
- Value of Electrocardiogram in the Differentiation of Hypertensive Heart Disease, Hypertrophic Cardiomyopathy, Aortic Stenosis, Amyloidosis, and Fabry DiseaseThe American Journal of Cardiology, 2012
- Electrocardiographic changes in early recognition of Fabry diseaseHeart, 2011
- PQ Interval in Patients With Fabry DiseaseThe American Journal of Cardiology, 2010
- Cellular basis and mechanism underlying normal and abnormal myocardial repolarization and arrhythmogenesisAnnals of Medicine, 2004
- A point-score system for the ECG diagnosis of left ventricular hypertrophyAmerican Heart Journal, 1968